Načítá se...
Response rates of standard interferon therapy in chronic HCV patients of Khyber Pakhtunkhwa (KPK)
BACKGROUND: Interferon based therapy is used to eradicate the Hepatitis C Virus from the bodies of the infected individuals. HCV is highly prevalent in Khyber Pakhtunkhwa (KPK) that is why it is important to determine the response of standard interferon based therapy in Chronic HCV patients of the r...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3284448/ https://ncbi.nlm.nih.gov/pubmed/22244529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-9-18 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|